Cancer is a tragic plague that wracks our world with suffering. Most Americans have been impacted by this horrific disease in a personal or professional way. Hodgkin Lymphoma is a blood cancer that invades the lives of thousands every year, but the tragic fact about this type of cancer is that it usually targets young adults. Hodgkin Lymphoma is not in the spotlight often due in part to its rarity and the fact that treatment for newly diagnosed patients didn’t change for over 40 years. Fortunately, Adcetris offers new hope for Hodgkin Lymphoma treatment.
Ads by Google
Drug Clinical Trials
Kidney cancer is amongst the 10 most common cancers known to mankind according to the American Cancer Society, and the disease is often fatal as the percentage of Americans diagnosed with kidney cancer continues to climb higher each year. Fortunately, the future is looking brighter with the introduction of new kidney cancer treatments and continuing research by brilliant scientists.
The Food and Drug Administration (FDA) granted the Breakthrough Therapy status for the Swiss pharmaceutical company Roche's drug Balovaptan in January 2018.
Prescription drugs used to treat men's hair loss and enlarged prostate could have unintended side effects that were never reported in clinical trials.
Researchers at the Imperial College London are exploring a new treatment for multiple sclerosis that resets the immune system.
The physicians are targeted by pharmaceutical reps specifically assigned to work for the purpose of attracting physicians to order these laboratory tests.
A new analysis of studies suggests cholesterol lowering drugs known as statins may not be as effective for preventing heart attack and stroke as we have been lead to believe. According to an expert review, the drugs do lower cholesterol. But claims about how well the drugs prevent heart disease have been exaggerated.